Follow The Filings

BCAB BioAtla

BioAtla earnings company data as of 7:30 PM ET 8/20

History

1 period, newest first. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q2 13 Aug EPS — 0.27 —
Rev — — —

Insider trades

Open-market buys and sales by BCAB's executives, directors and 10% owners in the last 12 months, from their Form 4s

All BCAB insider trades
  • None no insider bought on the open market
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales

No open-market buys or sales on file.

Also filed in the last 12 months, not counted as buying or selling: 17 share withholdings for taxes and 3 stock grants.

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
S-1
8-K 1.01,1.02,3.02,9.01
8-K 5.02,9.01
8-K 3.01
10-Q
8-K 5.07
DEF 14A
DEFA14A
10-Q
10-K/A
8-K 8.01,9.01
8-K 2.02,7.01
10-K
8-K 5.02,5.07
424B2
424B2 PROSPECTUS SUPPLEMENT NO. 2
424B2
8-K 2.02,2.05,5.02,7.01,8.01,9.01
DEFA14A
8-K 8.01
8-K 3.01,7.01
8-K 5.03,5.07,7.01,8.01,9.01
DEFA14A
8-K 3.02,5.03,5.07,8.01,9.01
8-K 1.01,3.02,7.01,9.01

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.